The BRAF Inhibitor Vemurafenib Activates Mitochondrial Metabolism and Inhibits Hyperpolarized Pyruvate-Lactate Exchange in BRAF-Mutant Human Melanoma Cells. (2016)
Attributed to:
Evaluation of non-invasive metabolic imaging biomarkers for novel RAF/MEK1/2-targeted anti-cancer agents
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1158/1535-7163.mct-16-0068
PubMed Identifier: 27765851
Publication URI: http://europepmc.org/abstract/MED/27765851
Type: Journal Article/Review
Volume: 15
Parent Publication: Molecular cancer therapeutics
Issue: 12
ISSN: 1535-7163